These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31383052)

  • 1. Optimal Melatonin Dose in Older Adults: A Clinical Review of the Literature.
    Pierce M; Linnebur SA; Pearson SM; Fixen DR
    Sr Care Pharm; 2019 Jul; 34(7):419-431. PubMed ID: 31383052
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.
    Vural EM; van Munster BC; de Rooij SE
    Drugs Aging; 2014 Jun; 31(6):441-51. PubMed ID: 24802882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
    Tuft C; Matar E; Menczel Schrire Z; Grunstein RR; Yee BJ; Hoyos CM
    Clin Interv Aging; 2023; 18():49-59. PubMed ID: 36660543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD009178. PubMed ID: 27851868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of the Efficacy and Safety of Over-the-Counter Medications Used in Older People for the Treatment of Primary insomnia.
    Almond SM; Warren MJ; Shealy KM; Threatt TB; Ward ED
    Sr Care Pharm; 2021 Feb; 36(2):83-92. PubMed ID: 33509331
    [No Abstract]   [Full Text] [Related]  

  • 6. Melatonin: therapeutic use in sleep disorders.
    Chase JE; Gidal BE
    Ann Pharmacother; 1997 Oct; 31(10):1218-26. PubMed ID: 9337448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for prescribing melatonin.
    Avery D; Lenz M; Landis C
    Ann Med; 1998 Feb; 30(1):122-30. PubMed ID: 9556099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of sleep disorders and melatonin.
    Xie Z; Chen F; Li WA; Geng X; Li C; Meng X; Feng Y; Liu W; Yu F
    Neurol Res; 2017 Jun; 39(6):559-565. PubMed ID: 28460563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG; Rigaud AS
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pre-pandemic melatonin treatment for sleep disorders and COVID-19 infection. A retrospective cross-sectional study].
    Valiensi SM; Folgueira A; Vera VA; González Cardozo A; Cardinali DP; Rugiero M
    Vertex; 2022 Mar; XXXIII(155):13-24. PubMed ID: 35438682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder.
    Bendz LM; Scates AC
    Ann Pharmacother; 2010 Jan; 44(1):185-91. PubMed ID: 20028959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review.
    Bueno APR; Savi FM; Alves IA; Bandeira VAC
    Arq Neuropsiquiatr; 2021 Aug; 79(8):732-742. PubMed ID: 34550191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW;
    PLoS Med; 2018 Jun; 15(6):e1002587. PubMed ID: 29912983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine for sleep disturbances in older adults.
    Gooneratne NS
    Clin Geriatr Med; 2008 Feb; 24(1):121-38, viii. PubMed ID: 18035236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options in the management of sleep disorders in visually impaired children: a systematic review.
    Khan SA; Heussler H; McGuire T; Dakin C; Pache D; Norris R; Cooper D; Charles B
    Clin Ther; 2011 Feb; 33(2):168-81. PubMed ID: 21497703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I
    Sleep Med Rev; 2005 Feb; 9(1):41-50. PubMed ID: 15649737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the pharmacological management of non-24-h sleep-wake disorder.
    Nishimon S; Nishino N; Nishino S
    Expert Opin Pharmacother; 2021 Jun; 22(8):1039-1049. PubMed ID: 33618599
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: A systematic review.
    Moroni I; Garcia-Bennett A; Chapman J; Grunstein RR; Gordon CJ; Comas M
    Sleep Med Rev; 2021 Jun; 57():101431. PubMed ID: 33549911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.